{
  "profile_url": "https://www.moffitt.org/research-science/researchers/joseph-pidala/",
  "last_updated": "2025-11-21T22:50:24.868574",
  "researcher_id": "5469",
  "degrees": [
    "MD"
  ],
  "title": "",
  "primary_program": "blood and marrow transplant and cellular immunotherapy",
  "research_program": "immuno-oncology",
  "overview": "The major focus of my research is to translate biologic understanding of graft vs. host disease (GVHD), a major complication of transplantation, into new strategies for prevention and therapy of this syndrome.",
  "research_interests": [
    "Acute GVHD prevention Chronic GVHD prevention, therapy, and allied outcomes research Study of immune tolerance development after transplant\n  *"
  ],
  "associations": [
    "Blood and Marrow Transplant and Cellular Immunotherapy",
    "Immuno-Oncology Program"
  ],
  "education": [
    {
      "type": "Graduate",
      "institution": "University of South Florida, MS"
    },
    {
      "type": "Medical School",
      "institution": "University of South Florida",
      "degree": "MD"
    },
    {
      "type": "Internship",
      "institution": "Beth Israel Deaconess Medical Center",
      "position": "Intern",
      "specialty": "/Resident - Internal Medicine"
    },
    {
      "type": "Fellowship",
      "institution": "H Lee Moffitt Cancer Center & Research Institute",
      "specialty": "Hematology-Oncology"
    },
    {
      "type": "Board Certification",
      "institution": "Internal Medicine",
      "certification": "Medical Oncology"
    }
  ],
  "publications": [
    {
      "title": "Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity",
      "pubmed_id": "41015085",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Louloudis IE, Chen YB, Spyrou N, Alousi A, Katsivelos N, Ayuk F, Weber D, Hogan WJ, Etra AM, Qayed M, Aguayo-Hiraldo P, Akahoshi Y, Malki MMA, Bola\u00f1os-Meade J, Chanswangphuwana C, Diniz M, Eder M, Hexner E, Kitko CL, Kraus S, Merli P, Olson T, MacMillan ML, Pidala J, Reshef R, Schechter T, W\u00f6lfl M, Baez J, Eng G, Gleich S, Young R, Nakamura R, Ferrara JLM, Levine JE",
      "journal": "Transplant Cell Ther"
    },
    {
      "title": "Obesity Associations with Chronic Graft-Versus-Host Disease",
      "pubmed_id": "40998267",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Ardila V, Onstad L, Carpenter P, Pidala J, Kitko C, Jurdi NE, Lee SJ, Hamilton BK",
      "journal": "Transplant Cell Ther"
    },
    {
      "title": "NIH Chronic Graft-Versus-Host Disease Consensus Conference",
      "pubmed_id": "40409691",
      "pmc_id": "PMC12354025",
      "year": "2025",
      "publication_date": "2025 Update",
      "authors": "Lee SJ, Williams KM, Sarantopoulos S, Kitko CL, Cutler C, Pidala J, Hill GR, DeFilipp Z, Greinix HT, Wolff D, Paczesny S, Cuvelier GDE, Schultz KR, Pavletic SZ"
    },
    {
      "title": "Hematopoietic Cell Transplantation, Version 3",
      "pubmed_id": "41067275",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Loren AW, Mielcarek M, Bola\u00f1os-Meade J, Brammer J, Cowden M, Di Stasi A, El-Jawahri A, Elmariah H, Gundabolu K, Gutman J, Ho V, Hoeg RT, Horwitz M, Jamy O, Kassim A, Dabaja MK, Lee L, Logan A, Luszcak C, Magenau JM, Martin TG, Mittal V, Moreira J, Muffly L, Nakamura R, Nawas M, Nieto Y, Ninos C, Oliai C, Papanicolaou G, Pidala J, Randolph B, Schroeder MA, Tessier J, Topal J, Tzachanis D, Varshavsky-Yanovsky AN, Jones F, Stehman K"
    },
    {
      "title": "Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide",
      "pubmed_id": "40617898",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Schmitz J, Gaskill E, Price S, Cao B, Kim J, Baluch A, Klinkova O, Faramand R, Mishra A, Perez L, Khimani F, Lazaryan A, Ochoa-Bayona JL, Liu H, Mirza AS, Nieder M, Anasetti C, Nishihori T, Pidala JA, Bejanyan N, Elmariah H",
      "journal": "Bone Marrow Transplant"
    },
    {
      "title": "Impact of Obesity and Weight-Based Chemotherapy Dosing Adjustments on Outcomes of Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia",
      "pubmed_id": "41115629",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Gaskill E, Albanyan O, Naqvi SMH, Mo Q, Belfon A, Nishihori T, Faramand R, Lazaryan A, Hansen DK, Khimani F, Mishra A, Nieder M, Perez L, Liu H, Pidala J, Anasetti C, Bejanyan N, Elmariah H",
      "journal": "Transplant Cell Ther"
    },
    {
      "title": "Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation",
      "pubmed_id": "40966481",
      "year": "2025",
      "publication_date": "2025 Nov",
      "authors": "Lee SJ, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Farhadfar N, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, He N, Devine S, Shaw BE, Ciurea SO",
      "journal": "J Clin Oncol"
    },
    {
      "title": "Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis",
      "pubmed_id": "39454280",
      "pmc_id": "PMC11909441",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "Pidala JA, Kim J, Kalos D, Cutler CS, DeFilipp Z, Flowers ME, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko CL, Ponce DM, Sung AD, Tang H, Farhadfar N, Nemecek ER, Pusic I, Qayed M, Rangarajan HG, Hogan WJ, Etra AM, Jaglowski SM",
      "journal": "Blood Adv"
    },
    {
      "title": "HSR25-166: Linking COVID-Related Distress and Mental Health Service Utilization Among Allogeneic Hematopoietic Stem Cell Transplant Patients",
      "pubmed_id": "40157349",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "Smith HR, Horta M, Dougan SO, Washington SJ, Yates HC, Pidala J, Reblin M, Jim H, Sutton SK, Vinci C",
      "journal": "J Natl Compr Canc Ne"
    },
    {
      "title": "Elephantiasis nostra verrucosa in sclerodermatous chronic graft-versus-host disease",
      "pubmed_id": "39936157",
      "pmc_id": "PMC11810717",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "Mammadova J, Glass L, LaFave D, Pidala J, Lazaryan A",
      "journal": "JAAD Case Rep"
    }
  ],
  "grants": [
    {
      "description": "Title: A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity  \nAward Number: N/A  \nSponsor: Medical College of Virginia Foundation (MCVF)  \nMirza, A. (PD/PI), Pidala, J. ()",
      "title": "A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity",
      "sponsor": "Medical College of Virginia Foundation (MCVF)",
      "source": "Foundation",
      "investigators": [
        {
          "name": "Mirza, A.",
          "role": "PD/PI"
        },
        {
          "name": "Pidala, J.",
          "role": ""
        }
      ]
    },
    {
      "description": "Title: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical Centers UG1  \nAward Number: 5UG1HL108987-15  \nSponsor: National Heart, Lung, and Blood Institute (NHLBI)  \nPidala, J. (PD/PI)",
      "title": "Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical Centers UG1",
      "award_number": "5UG1HL108987-15",
      "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)",
      "investigators": [
        {
          "name": "Pidala, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Predicting the Quality of Response to Specific Treatments (PQRST)  \nAward Number: 5R01CA118953-16  \nSponsor: National Cancer Institute (NCI)  \nPidala, J. (PD/PI)",
      "title": "Predicting the Quality of Response to Specific Treatments (PQRST)",
      "award_number": "5R01CA118953-16",
      "sponsor": "National Cancer Institute (NCI)",
      "source": "NCI",
      "investigators": [
        {
          "name": "Pidala, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Close Assessment and Testing for Chronic Graft-versus-Host Disease (The CATCH Study)  \nAward Number: 5U01CA236229  \nSponsor: National Cancer Institute (NCI)  \nPidala, J. (PD/PI)",
      "title": "Close Assessment and Testing for Chronic Graft-versus-Host Disease (The CATCH Study)",
      "award_number": "5U01CA236229",
      "sponsor": "National Cancer Institute (NCI)",
      "source": "NCI",
      "investigators": [
        {
          "name": "Pidala, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Ustekinumab for Graft Versus Host Disease (IND 144540)  \nAward Number: 5R01FD006836-04  \nSponsor: US Food & Drug Administration (FDA)  \nPidala, J. (PD/PI)",
      "title": "Ustekinumab for Graft Versus Host Disease (IND 144540)",
      "award_number": "5R01FD006836-04",
      "sponsor": "US Food & Drug Administration (FDA)",
      "investigators": [
        {
          "name": "Pidala, J.",
          "role": "PD/PI"
        }
      ]
    }
  ],
  "participating_trials": [
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-20888/",
      "trial_id": "20888",
      "title": "Predicting the Quality of Response to Specific Treatments (PQRST) Chronic GVHD Cohort",
      "condition": "Malignant Hematology",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-22114/",
      "trial_id": "22114",
      "title": "Randomized Phase II study of Belumosudil vs. Placebo for Preemptive Treatment of Chronic Graft vs. Host Disease",
      "condition": "Malignant Hematology",
      "intervention": "Belumosudil (); KD025 (Belumosudil); Placebo ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23275/",
      "trial_id": "23275",
      "title": "A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)",
      "condition": "Malignant Hematology",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23641/",
      "trial_id": "23641",
      "title": "A Phase 2, Open-label, Multicenter Study to Evaluate Safety, Tolerability, PK, and Efficacy of Vimseltinib in Adults With Active Chronic GVHD After Failure of Prior Systemic Therapy",
      "condition": "Malignant Hematology",
      "intervention": "Vimseltinib ()",
      "status": "Open"
    }
  ],
  "lab_page_url": "",
  "google_scholar_url": "",
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/PidalaJoseph_5469.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=5469"
  },
  "content_hash": "3b7d2995d54de24deb209dd9d66d8baef8600926e52cae963cd3cff25b0b860b",
  "researcher_name": "joseph pidala",
  "department": ""
}